Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’
Gespeichert in:
| Veröffentlicht in: | Eye (London) 2015-04, Vol.29 (4), p.589-590 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 590 |
|---|---|
| container_issue | 4 |
| container_start_page | 589 |
| container_title | Eye (London) |
| container_volume | 29 |
| creator | Andrijević Derk, B Benčić, G Corluka, V Zorić Geber, M Vatavuk, Z |
| description | |
| doi_str_mv | 10.1038/eye.2014.290 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4816361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1672609946</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-af3c748f3168f1313c6941c891305bffffa851f866f47f4442fb4a34c48dc0ae3</originalsourceid><addsrcrecordid>eNptkU1LI0EQhhtx0fhx8ywDXvbgZPt7ejwIEja7C8KCKHhrOp1qnTAznXTPBHLLz9j9e_6S7RhXVKxLH-rhrap-EDoheEgwU99gBUOKCR_SEu-gAeGFzAUXfBcNcClwTim930cHMc5woooC76F9KkRBhWIDNL6Beb3KOn-RPa3_jH0fskVvpsG0XRZtDcF3vqkgZs6HrF-CqTNwro-Vb7O4aqfBN_C0_nuEvjhTRzh-eQ_R3fj77ehnfv37x6_R1XVu0-QuN47ZgivHiFSOMMKsLDmxqiQMi4lLZZQgTknpeOE459RNuGHccjW12AA7RJfb3Hk_aWBqoe2CqfU8VI0JK-1Npd932upRP_il5opIJkkK-PoSEPyih9jppooW6tq04PuoiSyoxGXJZULPPqCz9D1tOm9DEYqZeKbOt5QNPsYA7nUZgvVGkE6C9EaQToISfvr2gFf4v5EE5Fsgplb7AOHN1M8C_wHtup1V</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1671203546</pqid></control><display><type>article</type><title>Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Andrijević Derk, B ; Benčić, G ; Corluka, V ; Zorić Geber, M ; Vatavuk, Z</creator><creatorcontrib>Andrijević Derk, B ; Benčić, G ; Corluka, V ; Zorić Geber, M ; Vatavuk, Z</creatorcontrib><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/eye.2014.290</identifier><identifier>PMID: 25572583</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/3161/3177 ; 692/700/565/545 ; Acetazolamide - therapeutic use ; Antihypertensive Agents - therapeutic use ; Carbonic Anhydrase Inhibitors - therapeutic use ; Choroid Diseases - drug therapy ; Correspondence ; Female ; Humans ; Laboratory Medicine ; Male ; Medicine ; Medicine & Public Health ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Prostaglandins F, Synthetic - therapeutic use ; Retinal Detachment - drug therapy ; Surgery ; Surgical Oncology ; Uveal Diseases - drug therapy</subject><ispartof>Eye (London), 2015-04, Vol.29 (4), p.589-590</ispartof><rights>Royal College of Ophthalmologists 2015</rights><rights>Copyright Nature Publishing Group Apr 2015</rights><rights>Copyright © 2015 Royal College of Ophthalmologists 2015 Royal College of Ophthalmologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c477t-af3c748f3168f1313c6941c891305bffffa851f866f47f4442fb4a34c48dc0ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816361/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816361/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,41469,42538,51300,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25572583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrijević Derk, B</creatorcontrib><creatorcontrib>Benčić, G</creatorcontrib><creatorcontrib>Corluka, V</creatorcontrib><creatorcontrib>Zorić Geber, M</creatorcontrib><creatorcontrib>Vatavuk, Z</creatorcontrib><title>Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><subject>692/699/3161/3177</subject><subject>692/700/565/545</subject><subject>Acetazolamide - therapeutic use</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Carbonic Anhydrase Inhibitors - therapeutic use</subject><subject>Choroid Diseases - drug therapy</subject><subject>Correspondence</subject><subject>Female</subject><subject>Humans</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Prostaglandins F, Synthetic - therapeutic use</subject><subject>Retinal Detachment - drug therapy</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Uveal Diseases - drug therapy</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkU1LI0EQhhtx0fhx8ywDXvbgZPt7ejwIEja7C8KCKHhrOp1qnTAznXTPBHLLz9j9e_6S7RhXVKxLH-rhrap-EDoheEgwU99gBUOKCR_SEu-gAeGFzAUXfBcNcClwTim930cHMc5woooC76F9KkRBhWIDNL6Beb3KOn-RPa3_jH0fskVvpsG0XRZtDcF3vqkgZs6HrF-CqTNwro-Vb7O4aqfBN_C0_nuEvjhTRzh-eQ_R3fj77ehnfv37x6_R1XVu0-QuN47ZgivHiFSOMMKsLDmxqiQMi4lLZZQgTknpeOE459RNuGHccjW12AA7RJfb3Hk_aWBqoe2CqfU8VI0JK-1Npd932upRP_il5opIJkkK-PoSEPyih9jppooW6tq04PuoiSyoxGXJZULPPqCz9D1tOm9DEYqZeKbOt5QNPsYA7nUZgvVGkE6C9EaQToISfvr2gFf4v5EE5Fsgplb7AOHN1M8C_wHtup1V</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Andrijević Derk, B</creator><creator>Benčić, G</creator><creator>Corluka, V</creator><creator>Zorić Geber, M</creator><creator>Vatavuk, Z</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150401</creationdate><title>Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’</title><author>Andrijević Derk, B ; Benčić, G ; Corluka, V ; Zorić Geber, M ; Vatavuk, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-af3c748f3168f1313c6941c891305bffffa851f866f47f4442fb4a34c48dc0ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>692/699/3161/3177</topic><topic>692/700/565/545</topic><topic>Acetazolamide - therapeutic use</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Carbonic Anhydrase Inhibitors - therapeutic use</topic><topic>Choroid Diseases - drug therapy</topic><topic>Correspondence</topic><topic>Female</topic><topic>Humans</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Prostaglandins F, Synthetic - therapeutic use</topic><topic>Retinal Detachment - drug therapy</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Uveal Diseases - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrijević Derk, B</creatorcontrib><creatorcontrib>Benčić, G</creatorcontrib><creatorcontrib>Corluka, V</creatorcontrib><creatorcontrib>Zorić Geber, M</creatorcontrib><creatorcontrib>Vatavuk, Z</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrijević Derk, B</au><au>Benčić, G</au><au>Corluka, V</au><au>Zorić Geber, M</au><au>Vatavuk, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>29</volume><issue>4</issue><spage>589</spage><epage>590</epage><pages>589-590</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>25572583</pmid><doi>10.1038/eye.2014.290</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-222X |
| ispartof | Eye (London), 2015-04, Vol.29 (4), p.589-590 |
| issn | 0950-222X 1476-5454 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4816361 |
| source | MEDLINE; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | 692/699/3161/3177 692/700/565/545 Acetazolamide - therapeutic use Antihypertensive Agents - therapeutic use Carbonic Anhydrase Inhibitors - therapeutic use Choroid Diseases - drug therapy Correspondence Female Humans Laboratory Medicine Male Medicine Medicine & Public Health Ophthalmology Pharmaceutical Sciences/Technology Prostaglandins F, Synthetic - therapeutic use Retinal Detachment - drug therapy Surgery Surgical Oncology Uveal Diseases - drug therapy |
| title | Reply to: ‘Four quadrant sclerotomies for uveal effusion syndrome’ |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to:%20%E2%80%98Four%20quadrant%20sclerotomies%20for%20uveal%20effusion%20syndrome%E2%80%99&rft.jtitle=Eye%20(London)&rft.au=Andrijevi%C4%87%20Derk,%20B&rft.date=2015-04-01&rft.volume=29&rft.issue=4&rft.spage=589&rft.epage=590&rft.pages=589-590&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/eye.2014.290&rft_dat=%3Cproquest_pubme%3E1672609946%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1671203546&rft_id=info:pmid/25572583&rfr_iscdi=true |